Keyphrases
Adrenoleukodystrophy
100%
X-linked Adrenoleukodystrophy (X-ALD)
100%
Newborn Screening
100%
International Experience
100%
Natural History
18%
ABCD1 Gene
9%
Early Surveillance
9%
Cerebral Demyelination
9%
Variants of Uncertain Significance
9%
Ethical Issues
9%
Screening Algorithm
9%
Adrenal Insufficiency
9%
Taiwan
9%
Prognostic Biomarker
9%
Variable Phenotype
9%
Genotype-phenotype Correlation
9%
Leukodystrophy
9%
Early Detection
9%
American States
9%
Mass Spectrometry
9%
Common Challenges
9%
Estimated Incidence
9%
Timely Treatment
9%
At Birth
9%
Life-sustaining Treatment
9%
Netherlands
9%
Law
9%
Japan
9%
Gene Sequencing
9%
Italy
9%
Screening Protocol
9%
Medicine and Dentistry
Newborn Screening
100%
Adrenoleukodystrophy
100%
Mass Spectrum
8%
Gene Sequence
8%
Genotype Phenotype Correlation
8%
Demyelination
8%
Biological Marker
8%
ABCD1
8%
Disease
8%
Leukodystrophy
8%
Adrenal Insufficiency
8%
Childbirth
8%
Biochemistry, Genetics and Molecular Biology
Adrenoleukodystrophy
100%
Newborn Screening
100%
ABCD1
8%
Mass Spectrometry
8%
Gene Sequence
8%
Genotype Phenotype Correlation
8%
